2010
DOI: 10.1016/j.idairyj.2009.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: Potential interest of prebiotics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 44 publications
(28 citation statements)
references
References 45 publications
0
28
0
Order By: Relevance
“…In obese animals, the dietary supplementation with inulin-type fructans boosts the number of bifidobacteria in the cecum, as well as the production of hormones secreted by host gut endocrine L cells, including peptide YY and glucagon-like peptide (GLP-1 and GLP-2) [13,24,50,51]. The production of GLP-1 is namely responsible for the improvement of hepatic insulin resistance and steatosis, for the decrease in blood glucose, and for the maintenance of satiety level in obese mice or rats [50].…”
Section: The Gut Microbiota: a Novel Target In The Nutritional Contromentioning
confidence: 99%
See 1 more Smart Citation
“…In obese animals, the dietary supplementation with inulin-type fructans boosts the number of bifidobacteria in the cecum, as well as the production of hormones secreted by host gut endocrine L cells, including peptide YY and glucagon-like peptide (GLP-1 and GLP-2) [13,24,50,51]. The production of GLP-1 is namely responsible for the improvement of hepatic insulin resistance and steatosis, for the decrease in blood glucose, and for the maintenance of satiety level in obese mice or rats [50].…”
Section: The Gut Microbiota: a Novel Target In The Nutritional Contromentioning
confidence: 99%
“…An increase in LPS concentrations occurs in obese and diabetic animals, but also in humans [13]. In fact, the endotoxemia remains quite modest (the concentration of LPS is approximately doubled in obesity), but when reproduced by chronic injection of exogenous LPS, is able to reproduce the loss of insulin sensitivity present in the obese mice [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…This mechanism is associated with the ability of soluble fibers to form viscous solutions that prolong gastric emptying, consequently inhibiting the transport of glucose, triglycerides and cholesterol across the intestine [70][71][72]. Recently, it was observed that both soluble and insoluble DFs also modifies carbohydrate metabolism by influencing the expression of hormones such as glucose-dependent insulin tropic polypeptide and glucagon-like peptide-1, that stimulate postprandial insulin release, enhance glucose tolerance, and delay gastric emptying [73][74][75][76].…”
Section: Fiber Carbohydrate Metabolism and Diabetes Mellitusmentioning
confidence: 99%
“…Increasing evidence linking gut flora to human health and diseases have inspired further research regarding the possible link between gut flora and obesity, which has led to the notion that prebiotics could be harnessed as potential therapeutic agents or management tools to prevent and treat obesity and the metabolic syndrome [4,5,7,20,52]. The metabolic syndrome is a cluster of metabolic abnormalities, including abdominal obesity, type 2 diabetes mellitus and cardiovascular diseases [86,87].…”
Section: Obesity and The Metabolic Syndromementioning
confidence: 99%
“…Recently it has also been recognized that this dynamic yet stable ecosystem plays a role in conditions such as obesity and diabetes as well as in general well-being, from infancy to ageing [1][2][3][4][5][6][7][8]. Consequently, an increasing number of studies which explore the potential of promoting health by nutrition focuses on possible ways to influence and modulate the composition and activity of the gut flora towards a healthier one [4,[9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%